ACIP Updates Hib Vaccine Recommendations for American Indian and Alaska Native Infants
Why are health officials updating vaccine guidance for Native American infants?
The Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations for Haemophilus influenzae type b (Hib) vaccinati…
Health officials updated vaccine guidance to better protect American Indian and Alaska Native infants from a serious bacterial infection tha…
ACIP releases 2024 recommended immunization schedule for US adults aged 19 or older
What vaccines should adults get this year? Here's the official 2024 schedule
The Advisory Committee on Immunization Practices has published its 2024 recommended immunization schedule for adults aged 19 years or older …
The official 2024 vaccine schedule for adults in the United States is out, guiding doctors and patients on which immunizations to consider t…
CDC recommends second 2024-2025 COVID-19 vaccine dose for older adults and immunocompromised persons
Who should get a second COVID-19 shot this fall? The CDC has new advice
The CDC has issued a recommendation for adults aged 65 years and older and persons aged 6 months and older with moderate or severe immunocom…
The CDC now recommends a second 2024-2025 COVID-19 vaccine dose six months after your last shot for adults 65 and older or those with weaken…
ACIP Recommends 21-Valent Pneumococcal Conjugate Vaccine as Option for Some U.S. Adults
U.S. health advisors recommend new pneumococcal vaccine option for adults
The Advisory Committee on Immunization Practices has issued a recommendation report for U.S.
U.S. health advisors now list a new 21-valent pneumococcal vaccine as an option for some adults to help prevent pneumonia and meningitis.
ACIP Recommends 2024-25 COVID-19 Vaccines for Persons Aged 6 Months and Older
Who should get the updated COVID-19 vaccine this fall?
The Advisory Committee on Immunization Practices has issued recommendations for the 2024-25 COVID-19 vaccines for persons aged 6 months and …
Updated COVID-19 vaccines are coming this fall for everyone six months and older in the United States as the official review process moves f…
Survey describes vaccination coverage by age 2 years for US children born in 2021 and 2022
How many toddlers are getting their recommended shots? A new report looks
An observational survey report describes vaccination coverage by age 24 months for US children born in 2021 and 2022.
A new report tracks how many toddlers born in 2021 and 2022 received their recommended shots by age two.
RSV Immunization Coverage Among US Infants Receiving Nirsevimab or Maternal Vaccination
How many infants are getting new RSV protection? A first look
An observational report describes RSV immunization coverage among US infants born from October 2023 to March 2024 who received nirsevimab mo…
For the first time, doctors have tools to protect youngest babies from RSV with new shots or pregnancy vaccines.
CDC recommends clesrovimab for preventing severe RSV lower respiratory infections in infants
CDC recommends new antibody to protect infants from severe RSV
The CDC has issued a recommendation for the use of clesrovimab to prevent severe respiratory syncytial virus-associated lower respiratory tr…
The CDC now recommends a new antibody to help protect infants from severe respiratory syncytial virus infections.
ACIP Issues Recommendations for Pfizer Pentavalent Meningococcal Vaccine in People 10+
Who should get the new five-strain meningitis vaccine? Experts weigh in
The Advisory Committee on Immunization Practices has issued a recommendation report for the use of Pfizer's pentavalent meningococcal vaccin…
A national committee recommends Pfizer's new five-strain meningitis vaccine for people aged 10 and older in the United States.
ACIP Recommends JYNNEOS Vaccine for Adults at Risk During Mpox Outbreaks
Health Panel Recommends Mpox Vaccine for At-Risk Adults During Outbreaks
A 2023 ACIP recommendation report advises use of the JYNNEOS vaccine for persons aged 18 years and older at risk for mpox during an outbreak…
U.S. health experts now recommend the JYNNEOS vaccine for adults at risk of mpox during outbreaks to help protect public health.
Reference-free computational method identifies spike-specific BCR sequences with over 90% purity in mRNA vaccinees
New computational method identifies vaccine-specific immune cells with high precision
An observational methodological study in healthy SARS-CoV-2 mRNA vaccine recipients evaluated a reference-free computational framework (LM-Q…
Researchers developed a computational method to identify immune cells that respond specifically to vaccines.
Pilot study finds cytokine differences between anti-NMDAR and viral encephalitis
Could a simple blood test help tell two dangerous brain inflammations apart?
A retrospective pilot cohort of 45 patients found significant alterations in CSF/serum albumin ratio, IL-4, and IL-17A levels between anti-N…
A simple blood test might help doctors quickly tell apart two dangerous brain inflammations by spotting unique protein patterns in patients.